TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects | Zendy

Ilaria Cavazzana | Zendy; Francesca BobbioPallavicini | Zendy; Chiara Bazzani | Zendy; E. Bravi | Zendy; Stefania Zingarelli | Zendy; Angela Ceribelli | Zendy; Roberto Caporali | Zendy; Roberto Cattaneo | Zendy; Franco Franceschini | Zendy; Carlomaurizio Montecucco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

Author(s) -

Ilaria Cavazzana,

Francesca BobbioPallavicini,

Chiara Bazzani,

E. Bravi,

Stefania Zingarelli,

Angela Ceribelli,

Roberto Caporali,

Roberto Cattaneo,

Franco Franceschini,

Carlomaurizio Montecucco

Publication year - 2011

Publication title -

reumatismo

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.294

H-Index - 25

eISSN - 2240-2683

pISSN - 0048-7449

DOI - 10.4081/reumatismo.2006.275

Subject(s) - medicine , rheumatoid arthritis , anti nuclear antibody , arthritis , gastroenterology , etanercept , antibody , anti dsdna antibodies , systemic lupus erythematosus , autoimmune disease , tnf inhibitor , immunology , autoantibody , disease

To analyse efficacy and safety of anti-TNFalpha treatment in 17 patients with rheumatoid arthritis (AR) and anti-Ro antibodies, in order to detect difference in clinical and immunological response.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research